
We are molecular pathology laboratory specializing in genetic testing to deliver personalized medicine in timely and accurate manner. Operating in Jakarta, KalGen Laboratory is ISO15189 accredited for both KRAS and EGFR mutation genetic testing. Currently KRAS and EGFR tests are required to match colorectal and lung cancer patients to cetuximab and tyrosine kinase inhibitors (gefitinib and erlotinib), respectively. Since 2009, KalGen has performed more than genetic testing from various clinical samples such as formalin fixed paraffin embedded tissues and cytological samples. We have partnered…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.